Biocon Limited is a biopharmaceutical company that specializes in the manufacturing of pharmaceuticals, medicinal chemical products, and botanical products. The company operates in various segments including Generics, Novel Biologics, Biosimilars, and Research Services. Its primary focus lies in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. Additionally, Biocon Limited offers integrated services for the discovery, development, and manufacturing of both small and large molecules. With a global presence, the company serves customers in approximately 120 countries. Founded in 1978, Biocon Limited is headquartered in Bengaluru, India.
Navigation section
Biocon Limited
- 368.25 -1.35(-0.37%) 368.25 -1.15(-0.31%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 364.00 364.05 | 374.95 374.90 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 237.65 (11-Dec-2023) 237.95 (11-Dec-2023) | 395.80 (17-Sep-2024) 395.65 (17-Sep-2024) |
- Open
- 370.00 369.60
- Previous Close
- 369.60 369.40
- Volume
- 20.44
- Total Traded value
- 75.37 (₹ Lakhs)
- Upper circuit
- 406.55 301.60
- Lower circuit
- 332.65 246.80
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 20 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 369.20 | 20.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 20 |
Fundamentals
| Market Cap: | ₹442.12 Cr |
| PE Ratio (TTM): | 1,052.14 |
| PB Ratio: | 4.06 |
| Industry P/E: | 24.21 |
| Debt to Equity: | - |
| ROE: | 0.39 |
| EPS (TTM): | 0.35 |
| Book Value: | 89.94 |
| Face Value: | 5.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 518.70 Cr | 513.20 Cr | 506.70 Cr | 555.00 Cr | 489.50 Cr |
| Profit | 34.70 Cr | 46.60 Cr | 1,810.80 Cr | 35.20 Cr | 987.50 Cr |
| Expense | 537.10 Cr | 519.30 Cr | 628.20 Cr | 568.40 Cr | 491.50 Cr |
| Comprehensive income | 31.90 Cr | 50.30 Cr | 1,813.00 Cr | 38.00 Cr | 985.90 Cr |
| EPS | 0.29 | 0.39 | 15.14 | 0.29 | 8.26 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Biocon Limited | Apr, 2004 Apr, 2004 | Pharmaceuticals Pharmaceuticals | BIOCON BIOCON |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Biocon Limited FAQ's
What is the range of today's stock performance for Biocon Limited?
Today's stock performance witnessed a fluctuation from a minimum of 364.00 on the NSE (National Stock Exchange) to a maximum of 374.95. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 364.05 to a high of 374.90.
What are the 52-week low and high values for Biocon Limited?
The stock's performance over the past 52 weeks reveals a low of 237.65 (occurred on 11-Dec-2023) and a high of 395.80 (achieved on 17-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 237.95 (on 11-Dec-2023), and the 52-week high is 395.65 (on 17-Sep-2024).
What was the opening and previous closing prices for Biocon Limited?
The stock's performance over the past 52 weeks reveals a low of 237.65 (occurred on 11-Dec-2023) and a high of 395.80 (achieved on 17-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 237.95 (on 11-Dec-2023), and the 52-week high is 395.65 (on 17-Sep-2024).
What is the total volume and traded value for Biocon Limited for the day?
The total volume is 20, and the total traded value is 75.37 (₹ Lakhs).
What are the upper and lower circuit limits for Biocon Limited?
The upper circuit limit is 406.55, and the lower circuit limit is 332.65.
What is the market cap and PE ratio for Biocon Limited?
The market cap is ₹442.12 Cr, and the PE ratio (TTM) is 23.45.
What is the PB ratio, industry P/E, and debt to equity ratio for Biocon Limited?
The PB ratio is 4.09, industry P/E is 24.21 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Biocon Limited?
ROE is 0.39, EPS is 0.35, book value is 89.94
What are the revenue and profit figures for the latest quarter and previous quarters for Biocon Limited?
In Sep 2023, Revenue is ₹5187000000.00, and Profit is ₹347000000.00. In Jun 2023, Revenue is ₹5132000000.00, and Profit is ₹466000000.00.
When was Biocon Limited listed, and what industry does it belong to?
The company, Biocon Limited, was listed in Apr 2004 and belongs to the Pharmaceuticals industry. Its NSE symbol is BIOCON.
What is the current shareholding pattern of the Biocon Limited?
As of latest available update, promoters hold 60.64%, the public holds 38.97%, and Employee Trusts holds 0.39.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
